You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MIRM Sale Disclosure
Peetz Christopher · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$815.24K
Peetz Christopher Chief Executive Officer
MIRM
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
MIRM daily price context
Close on/before transaction
$98.34
Sep 1, 2026
First close after public filing
$100.9
Sep 4, 2026
30-day return after filing
-19.3%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,312 shares @ $98.08
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001614740-26-000013
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$3.05M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. MIRM | Exercise | Sep 1, 2026 | $0 |
| Mirum Pharmaceuticals, Inc. MIRM | Exercise | Sep 1, 2026 | $88.08K |
| Mirum Pharmaceuticals, Inc. MIRM Current | Sale | Sep 1, 2026 | $815.24K |
| Mirum Pharmaceuticals, Inc. MIRM | Sale | Sep 1, 2026 | $2.15M |